Table 1.

Data collection table.

Feature	Variable
General information	• HTA/NITAG agency • Year • Report Title • Country • Population • Recommendation: • Taking a stance (positive/negative) either in relation to the implementation of a PCV into the countries NIP, the change of one PCV to another in an existing NIP, or the change in vaccination schedule for an already implemented PCV NIP • No recommendation; neutral assessment
Epidemiological data for IPD, AOM and pneumonia	• Epidemiological context (type of PCV, year of introduction etc.) Inclusion of evidence on: • Incidence • Prevalence • Mortality • Clinical presentation (for IPD, pneumonia) • Serotype distribution • % attributable to S. pneumoniae
Health economic data	• Description of health economic models • Description of major assumptions in model • Model inputs for costs, utilities, epidemiologic, resource use, etc. • Outcomes presented • Conclusion
Other	• HTA/NITAG critiques of evidence